Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS).

Saved in:
Bibliographic Details
Title: Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS).
Authors: Quinquenel A; Hôpital Robert Debré, Reims, France. aquinquenel@chu-reims.fr., Leprêtre S; Centre Henri-Becquerel, Rouen, France., Dilhuydy MS; Hôpital du Haut-Lévêque, Bordeaux, France., Bussot L; CHU Grenoble Alpes, Grenoble, France., Marjanovic Z; Hôpital Saint-Antoine, Paris, France., Benbrahim O; CHR Orléans, Orléans, France., Guièze R; CHU Estaing, Clermont-Ferrand, France., Santagostino A; Hôpital Simone Veil, Troyes, France., Dartigeas C; CHU Tours, Tours,, France., Feugier P; CHU Régional de Nancy, Vandoeuvre lès Nancy, France., Roos-Weil D; CHU Pitié Salpêtrière, Paris, France., Damaj G; CHU Caen, Caen, France., Laribi K; CH le Mans, Le Mans, France., Ysebaert L; IUCT-Oncopôle , Toulouse, France., Levy V; Hôpital Avicenne, Bobigny, France.
Source: Annals of hematology [Ann Hematol] 2025 Oct; Vol. 104 (10), pp. 5565.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0584
DOI:10.1007/s00277-025-06632-3